SEC Company Response from MYMETICS CORP (CIK 0000927761) — Jan 3, 2020
MYMETICS CORP (CIK 0000927761)
Date: Jan. 3, 2020 · CIK: 0000927761 · Accession: 0001654954-20-000058
AI Filing Summary & Sentiment
File numbers found in text: 000-25132
Letter
Via Edgar Correspondence Office of Life Sciences Division of Corporation Finance Securities and Exchange Commission Mymetics Corporation Preliminary Information Statement on Schedule 14C Filed December 27, 2019 File No. 000-25132
Dear Mr. Edwards:
We have received your correspondence dated December 31, 2019. We have addressed your comment by reproducing it and providing our response immediately thereafter.
General
Please revise your disclosure to describe any current plans, arrangements or understandings relating to the issuance of any of the newly authorized shares that would be available as a result of the proposed increase in authorized shares, including the terms of any current financing plans. If you have no such plans, arrangements or understandings, please revise your disclosure to so state.
Response: We have revised our Preliminary Information Statement on Schedule 14C in response to this comment.
We are filing on EDGAR for SEC access only a marked version of the Schedule 14C to reflect the changes referenced above in response to the SEC’s comment letter. If you have any further comments or questions regarding our response, please contact our legal counsel, Ernest M. Stern, Culhane Meadows PLLC at (301) 910-2030. If you cannot reach him, please contact the undersigned at ronald.kempers@mymetics.com.
Sincerely,
/s/
Ronald Kempers
Show Raw Text
CORRESP 1 filename1.htm Blueprint MYMETICS CORPORATION Route de la Corniche 4 1066 Epalinges, Switzerland January 3, 2020 Via Edgar Correspondence Chris Edwards Office of Life Sciences Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Mymetics Corporation Preliminary Information Statement on Schedule 14C Filed December 27, 2019 File No. 000-25132 Dear Mr. Edwards: We have received your correspondence dated December 31, 2019. We have addressed your comment by reproducing it and providing our response immediately thereafter. General Please revise your disclosure to describe any current plans, arrangements or understandings relating to the issuance of any of the newly authorized shares that would be available as a result of the proposed increase in authorized shares, including the terms of any current financing plans. If you have no such plans, arrangements or understandings, please revise your disclosure to so state. Response: We have revised our Preliminary Information Statement on Schedule 14C in response to this comment. We are filing on EDGAR for SEC access only a marked version of the Schedule 14C to reflect the changes referenced above in response to the SEC’s comment letter. If you have any further comments or questions regarding our response, please contact our legal counsel, Ernest M. Stern, Culhane Meadows PLLC at (301) 910-2030. If you cannot reach him, please contact the undersigned at ronald.kempers@mymetics.com. Sincerely, /s/ Ronald Kempers Ronald Kempers cc: Ernest M. Stern, Esq. (w/encl.) Encl.